Ensysce Biosciences, Inc. (ENSC) Return on equity 2024–2025
Ensysce Biosciences, Inc. (ENSC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-316.6%FY2025 · since FY2024: -215.4% → -316.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -316.6% | -101.3 pp |
| FY2024 | -215.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ENSC financial trends
ENSC RevenueENSC Net incomeENSC Net marginENSC Gross profitENSC Gross marginENSC Operating incomeENSC Operating marginENSC Operating cash flowENSC Free cash flowENSC Capital expendituresENSC Stock buybacksENSC Dividends paidENSC Total assetsENSC Total liabilitiesENSC Shareholders’ equityENSC overview →